相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis
Kenta Tezuka et al.
JOURNAL OF NEUROCHEMISTRY (2022)
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis
Eleonora Virgilio et al.
JOURNAL OF NEUROLOGY (2022)
BMI and Allostatic Load Are Directly Associated with Longitudinal Increase in Plasma Neurofilament Light among Urban Middle-Aged Adults
May A. Beydoun et al.
JOURNAL OF NUTRITION (2022)
Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis
Samar A. Zailaie et al.
IMMUNOLOGICAL INVESTIGATIONS (2022)
Longitudinal Analysis Suggests Epstein--Barr as Cause of Multiple Sclerosis
[Anonymous]
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
Connection between microstructural alterations detected by diffusion MRI and cognitive dysfunction in MS: A model-free analysis approach
Peter Farago et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Factors contributing to CSF NfL reduction over time in those starting treatment for multiple sclerosis: An observational study
Ide Smets et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Brain Volume Loss Can Occur at the Rate of Normal Aging in Patients with Multiple Sclerosis Who Are Free from Disease Activity
Joke Temmerman et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis From the MS-STAT Randomized Controlled Trial
Thomas E. Williams et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)
Associations between neurofilament light chain levels, disease activity and brain atrophy in progressive multiple sclerosis
Jarmila Szilasiova et al.
BIOMEDICAL PAPERS-OLOMOUC (2022)
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study
Igal Rosenstein et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Sustained reduction of serum neurofilament light chain over 7 years by alemtuzumab in early relapsing-remitting MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
High or increasing serum NfL is predictive of impending multiple sclerosis relapses
Simon Thebault et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
Kjetil Bjornevik et al.
SCIENCE (2022)
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
Hrishikesh Lokhande et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2022)
Neurofilament light chain concentration in an aging population
Aurelie Ladang et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)
CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
Zerrin Karaaslan et al.
EUROPEAN NEUROLOGY (2022)
Leptin levels are associated with multiple sclerosis risk
Martin Bistrom et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Neurofilaments in progressive multiple sclerosis: a systematic review
Thomas Williams et al.
JOURNAL OF NEUROLOGY (2021)
Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis
Tomas Uher et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis
Tobias Monschein et al.
JOURNAL OF NEUROLOGY (2021)
Altered brain network function during attention-modulated visual processing in multiple sclerosis
Daniel Vereb et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab
Alyssa A. Toorop et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Factors influencing serum neurofilament light chain levels in normal aging
Marisa Koini et al.
Aging-US (2021)
A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis
Soudeh Ghafouri-Fard et al.
METABOLIC BRAIN DISEASE (2021)
Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patients
C. Bridel et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
Charles A. Roach et al.
FRONTIERS IN NEUROLOGY (2021)
Serum neurofilament levels and patient-reported outcomes in multiple sclerosis
Kristin Galetta et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Obesity and the risk of Multiple Sclerosis. The role of Leptin
Mariano Marrodan et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
High serum neurofilament associates with diffuse white matter damage in MS
Maija Saraste et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Apparent changes in the epidemiology and severity of multiple sclerosis
Nils Koch-Henriksen et al.
NATURE REVIEWS NEUROLOGY (2021)
Diagnosis and Treatment of Multiple Sclerosis A Review
Marisa P. McGinley et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis
Robert J. Fox et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis
Sara Momtazmanesh et al.
REVIEWS IN THE NEUROSCIENCES (2021)
A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers
Keith R. Edwards et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
MengJiao Sun et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis
Yusuf Tamam et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Osteopontin levels are associated with late-time lower regional brain volumes in multiple sclerosis
Gergely Orsi et al.
SCIENTIFIC REPORTS (2021)
Long Non-coding RNAs and Circular RNAs: Insights Into Microglia and Astrocyte Mediated Neurological Diseases
Miaomiao Chen et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2021)
Serum GFAP and NfL levels in benign relapsing-remitting multiple sclerosis
Marja Niiranen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort study
Timo Uphaus et al.
EBIOMEDICINE (2021)
CSF Levels of CXCL12 and Osteopontin as Early Markers of Primary Progressive Multiple Sclerosis
Damiano Marastoni et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Health Economic Impact of Software-Assisted Brain MRI on Therapeutic Decision-Making and Outcomes of Relapsing-Remitting Multiple Sclerosis Patients-A Microsimulation Study
Diana M. Sima et al.
BRAIN SCIENCES (2021)
Profiling of Plasma Extracellular Vesicle Transcriptome Reveals That circRNAs Are Prevalent and Differ between Multiple Sclerosis Patients and Healthy Controls
Leire Iparraguirre et al.
BIOMEDICINES (2021)
Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity
Ruturaj Masvekar et al.
FRONTIERS IN NEUROSCIENCE (2021)
Ultrasensitive immunoassay allows measurement of serum neurofilament heavy in multiple sclerosis
Inge M. W. Verberk et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Protect Against Cognitive Impairment in Multiple Sclerosis
Emilio Portaccio et al.
FRONTIERS IN NEUROLOGY (2021)
Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis
Undine Proschmann et al.
FRONTIERS IN NEUROLOGY (2021)
Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab
Nicolas Fissolo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Mike P. Wattjes et al.
LANCET NEUROLOGY (2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light
Nicholas J. Ashton et al.
Nature Communications (2021)
Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis
Alessandro Maglione et al.
GENES (2021)
Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
Gergely Orsi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Neurofilament Light Chain (NfL) in Blood-A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke
Milos Pekny et al.
CELLS (2021)
CSF Chitinase 3-Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
Manuel Comabella et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Multiple Sclerosis circRNA Profile Defined Reveals Links to B-Cell Function
Anna E. Zurawska et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis A Randomized, Controlled Trial
Helene Hojsgaard Chow et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
Alok Bhan et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2021)
Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients
Kimberley Allen-Philbey et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
Apeng Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
YKL-40 promotes invasion and metastasis of bladder cancer by regulating epithelial mesenchymal transition
Hailong Hao et al.
ANNALS OF MEDICINE (2021)
Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
Jasmini Alagaratnam et al.
BMJ NEUROLOGY OPEN (2021)
Neurofilament Light Chain Levels Are Associated with Disease Activity Determined by No Evident Disease Activity in Multiple Sclerosis Patients
Jarmila Szilasiova et al.
EUROPEAN NEUROLOGY (2021)
miRNAs in Microglia: Important Players in Multiple Sclerosis Pathology
Alexander D. Walsh et al.
ASN NEURO (2021)
Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
C. B. Tauil et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2021)
Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS
Ruth Schneider et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
The Yin-Yang of osteopontin in nervous system diseases: damage versus repair
Giuseppe Cappellano et al.
NEURAL REGENERATION RESEARCH (2021)
Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation
Undine Proschmann et al.
FRONTIERS IN IMMUNOLOGY (2021)
Plasma neurofilaments correlate with disability in progressive multiple sclerosis patients
Diana Ferraro et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
Intrathecal immunoglobulins and neurofilament light after autologous haematopoietic stem cell transplantation for multiple sclerosis
Diane Larsson et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis
Kjetil Bjornevik et al.
JAMA NEUROLOGY (2020)
Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis
Joost Smolders et al.
ACTA NEUROLOGICA SCANDINAVICA (2020)
MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7
Lena Fritsche et al.
BRAIN PATHOLOGY (2020)
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province
Morteza Jafarinia et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2020)
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
Heidi Hogel et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology
Sarah Teuber-Hanselmann et al.
JOURNAL OF PATHOLOGY (2020)
microRNA and exosome profiling in multiple sclerosis
Marcin P. Mycko et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Benedicte Delcoigne et al.
NEUROLOGY (2020)
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
M. M. J. van den Berg et al.
PROGRESS IN NEUROBIOLOGY (2020)
Serum neurofilament light levels in normal aging and their association with morphologic brain changes
Michael Khalil et al.
NATURE COMMUNICATIONS (2020)
Identification and functional analysis of specific MS risk miRNAs and their target genes
Deling Luo et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Plasma copeptin levels in patients with multiple sclerosis
Mesrure Koseoglu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Confounding effect of blood volume and body mass index on blood neurofilament light chain levels
Ali Manouchehrinia et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Epidemiology of multiple sclerosis in Central Europe, update from Hungary
Tamas Biernacki et al.
BRAIN AND BEHAVIOR (2020)
Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
Egil Rosjo et al.
FRONTIERS IN NEUROLOGY (2020)
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
Michael Benatar et al.
NEUROLOGY (2020)
Exosomal neurofilament light: A prognostic biomarker for remote symptoms after mild traumatic brain injury?
Vivian A. Guedes et al.
NEUROLOGY (2020)
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
Marina Kleopatra Boziki et al.
BRAIN SCIENCES (2020)
A comprehensive review of non-coding RNAs functions in multiple sclerosis
Soudeh Ghafouri-Fard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Ludwig Kappos et al.
JAMA NEUROLOGY (2020)
Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients
Katariina Hanninen et al.
BRAIN AND BEHAVIOR (2020)
A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course
Andre Huss et al.
FRONTIERS IN NEUROLOGY (2020)
CSF chitinase 3-like-1 association with disability of primary progressive MS
Francisco Perez-Miralles et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Long Noncoding RNAs and Circular RNAs in Autoimmune Diseases
Valeria Lodde et al.
BIOMOLECULES (2020)
NfL as a biomarker for neurodegeneration and survival in Parkinson disease
David Backstrom et al.
NEUROLOGY (2020)
Ofatumumab versus Teriflunomide in Multiple Sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
RNA-Seq profiling of leukocytes reveals a sex-dependent global circular RNA upregulation in multiple sclerosis and 6 candidate biomarkers
Leire Iparraguirre et al.
HUMAN MOLECULAR GENETICS (2020)
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
Simon Thebault et al.
SCIENTIFIC REPORTS (2020)
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Xavier Ayrignac et al.
SCIENTIFIC REPORTS (2020)
Serum neurofilament-light concentration and real-world outcome in MS
Valerie Anderson et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)
Ratio and index of Neurofilament light chain indicate its origin in Guillain-Barre Syndrome
Peter Koertvelyessy et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Levels of brain-derived neurotrophic factor in patients with multiple sclerosis
Yvonne Naegelin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
Saul Reyes et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
Andre Huss et al.
BIOMEDICINES (2020)
Competing Endogenous RNA Networks as Biomarkers in Neurodegenerative Diseases
Leticia Moreno-Garcia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Renal function is associated with blood neurofilament light chain level in older adults
Shoshin Akamine et al.
SCIENTIFIC REPORTS (2020)
Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease
Leire Iparraguirre et al.
BIOMEDICINES (2020)
Intrathecally produced CXCL13: A predictive biomarker in multiple sclerosis
Krista D. DiSano et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)
The weak association between neurofilament levels at multiple sclerosis onset and cognitive performance after 9 years
Lucie Friedova et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS
L. Novakova et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Chitinase-3 like-protein-1 function and its role in diseases
Ting Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
Roos M. van der Vuurst de Vries et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome
Roos M. van der Vuurst de Vries et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Serum neurofilaments increase at progressive multifocal leukoencephalopathy onset in natalizumab-treated multiple sclerosis patients
Gloria Dalla Costa et al.
ANNALS OF NEUROLOGY (2019)
MALAT1 Genomic Variants and Risk of Multiple Sclerosis
Mohammad Mahdi Eftekharian et al.
IMMUNOLOGICAL INVESTIGATIONS (2019)
Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis
Farimah Masoumi et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
M. N. Olesen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
Ahmed Abdelhak et al.
FRONTIERS IN NEUROLOGY (2019)
Expression of disease-related miRNAs in white-matter lesions of progressive multiple sclerosis brains
Ajai Tripathi et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Osteopontin potentiates PM-induced IL-1α and IL-1β production via the ERK/JNK signaling pathway
Jian Wang et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2019)
Small non-coding RNAs as important players, biomarkers and therapeutic targets in multiple sclerosis: A comprehensive overview
Eliane Piket et al.
JOURNAL OF AUTOIMMUNITY (2019)
Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?
Thaleia Kalatha et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2019)
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY (2019)
Neurofilament light chain as a biomarker in neurological disorders
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease
Lijun Peng et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS
Alfredo Damasceno et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS
Brooke Rhead et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Early central vs. peripheral immunological and neurobiological effects of fingolimod-a longitudinal study
Tony Sehr et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Impact of B cells to the pathophysiology of multiple sclerosis
Borros M. Arneth
JOURNAL OF NEUROINFLAMMATION (2019)
Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis
Keith R. Edwards et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis
Lorenzo Gaetani et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS
Katja Akguen et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Serum neurofilament light chain in pediatric MS and other acquired demyelinating syndromes
Yu Yi M. Wong et al.
NEUROLOGY (2019)
Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
Ester Canto et al.
JAMA NEUROLOGY (2019)
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
Sara Gil-Perotin et al.
FRONTIERS IN NEUROLOGY (2019)
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
Simon Thebault et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
High-throughput RNA sequencing from paired lesional- and non-lesional skin reveals major alterations in the psoriasis circRNAome
Liviu-Ionut Moldovan et al.
BMC MEDICAL GENOMICS (2019)
Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases
Gildas Lepennetier et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Analysis of miRNA signatures in CSF identifies upregulation of miR-21 and miR-146a/b in patients with multiple sclerosis and active lesions
Maria Munoz-San Martin et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naive relapsing MS patients
Tobias Sejbaek et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Resolution of inflammation during multiple sclerosis
F. Ruiz et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis
Trygve Holmoy et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
Contributing factors to health-related quality of life in multiple sclerosis
Tamas Biernacki et al.
BRAIN AND BEHAVIOR (2019)
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience
C. De Fino et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Leptin rs7799039 polymorphism is associated with multiple sclerosis risk in Kuwait
Mohammed Dashti et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS
Irene Hakansson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
Maria Ines Herrera et al.
FRONTIERS IN NEUROLOGY (2019)
LncRNAs, MALAT1 and lnc-DC as potential biomarkers for multiple sclerosis diagnosis
Olfat G. Shaker et al.
BIOSCIENCE REPORTS (2019)
Multiple sclerosis - a review
R. Dobson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Not only cancer: the long non-coding RNA MALAT1 affects the repertoire of alternatively spliced transcripts and circular RNAs in multiple sclerosis
Giulia Cardamone et al.
HUMAN MOLECULAR GENETICS (2019)
Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
Gloria Dalla Costa et al.
NEUROLOGY (2019)
The Contribution of Various MRI Parameters to Clinical and Cognitive Disability in Multiple Sclerosis
Eszter Toth et al.
FRONTIERS IN NEUROLOGY (2019)
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial
Pierre de Flon et al.
ACTA NEUROLOGICA SCANDINAVICA (2019)
MRI phenotypes in MS Longitudinal changes and miRNA signatures
Christopher C. Hemond et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
Lekha Pandit
ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2019)
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease
Maria Liguori et al.
HUMAN MOLECULAR GENETICS (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Convective influx/glymphatic system: tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways
Nazira J. Albargothy et al.
ACTA NEUROPATHOLOGICA (2018)
Dysregulated Network of miRNAs Involved in the Pathogenesis of Multiple Sclerosis
Sanam Dolati et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
Clara Matute-Blanch et al.
BRAIN (2018)
Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis
Marije J. D. Huitema et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2018)
Cognitive impairment in early stages of multiple sclerosis is associated with high cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain
E. Quintana et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis
X. Montalban et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Immune-related miRNA expression patterns in peripheral blood mononuclear cells differ in multiple sclerosis relapse and remission
Natalia Baulina et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis
Irene Hakansson et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies
Sara Mariotto et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
Elmira Agah et al.
PLOS ONE (2018)
Association between circulating leptin levels and multiple sclerosis: a systematic review and meta-analysis
Xue-Feng Xie et al.
POSTGRADUATE MEDICAL JOURNAL (2018)
Multiple Sclerosis Pathology
Hans Lassmann
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Disease activity in progressive multiple sclerosis can be effectively reduced by cladribine
O. Yildiz et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Circular RNAs in Cancer - Lessons Learned From microRNAs
Mihnea Dragomir et al.
FRONTIERS IN ONCOLOGY (2018)
P2908Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study
S Aeschbacher et al.
EUROPEAN HEART JOURNAL (2018)
Neurofilaments and 10-year follow-up in multiple sclerosis
Alok Bhan et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression
Viviana Nociti et al.
PLOS ONE (2018)
Serum GFAP as a biomarker for disease severity in multiple sclerosis
A. Abdelhak et al.
SCIENTIFIC REPORTS (2018)
Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis
Nicoletta Nuzziello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
SOX4 inhibits oligodendrocyte differentiation of embryonic neural stem cells in vitro by inducing Hes5 expression
Luca Braccioli et al.
STEM CELL RESEARCH (2018)
Circular RNAs and Their Emerging Roles in Immune Regulation
Lan Yang et al.
FRONTIERS IN IMMUNOLOGY (2018)
CSF-Progranulin and Neurofilament Light Chain Levels in Patients With Radiologically Isolated Syndrome-Sign of Inflammation
Marc Pawlitzki et al.
FRONTIERS IN NEUROLOGY (2018)
Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis
Tanuja Chitnis et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Interpreting Non-coding Genetic Variation in Multiple Sclerosis Genome-Wide Associated Regions
Elvezia Maria Paraboschi et al.
FRONTIERS IN GENETICS (2018)
The novel roles of circular RNAs in metabolic organs
Zhi-Chun Zhang et al.
GENES & DISEASES (2018)
Identification of MS-specific serum miRNAs in an international multicenter study
Keren Regev et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)
Circulating immune cells in multiple sclerosis
A. P. Jones et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
J. Mellergard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2017)
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
Lenka Novakova et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Circulating microRNAs as biomarkers in progressive multiple sclerosis
Julia Vistbakka et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Epigenetic Modifications and Therapy in Multiple Sclerosis
Saeed Aslani et al.
NEUROMOLECULAR MEDICINE (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Circulating microRNAs as biomarkers in progressive multiple sclerosis
Julia Vistbakka et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis
Leire Iparraguirre et al.
HUMAN MOLECULAR GENETICS (2017)
Microarray analysis of circular RNA expression patterns in polarized macrophages
Yingying Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis
Giulia Cardamone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Early cognitive impairment along with decreased stress-induced BDNF in male and female patients with newly diagnosed multiple sclerosis
Barbora Prokopova et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis
Clara Matute-Blanch et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
M. Puthenparampil et al.
JOURNAL OF NEUROINFLAMMATION (2017)
High risk of early conversion to multiple sclerosis in clinically isolated syndromes with dissemination in space at baseline
Lorenzo Gaetani et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis
Piotr Iwanowski et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Antiviral Immunity and Circular RNA: No End in Sight
Cristhian Cadena et al.
MOLECULAR CELL (2017)
Defining active progressive multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands
Ester Quintana et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Serum neurofilament is associated with progression of brain atrophy and disability in early MS
Jens Kuhle et al.
NEUROLOGY (2017)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder
Oskar Hansson et al.
NEUROLOGY (2017)
OSTEOPONTIN-METALLOTHIONEIN I/II INTERACTIONS IN EXPERIMENTAL AUTOIMMUNUNE ENCEPHALOMYELITIS
Hrvoje Jakovac et al.
NEUROSCIENCE (2017)
Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
Jeffrey M. Gelfand et al.
NEUROTHERAPEUTICS (2017)
Neurofilaments and Neurofilament Proteins in Health and Disease
Aidong Yuan et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severityle
Keren Regev et al.
JAMA NEUROLOGY (2017)
Defining active progressive multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands
Ester Quintana et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Prevalence of of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome
Sandi Daniel et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2017)
Pharmacodynamic effects of daclizumab in the intrathecal compartment
Mika Komori et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis
Igor Selmaj et al.
ANNALS OF NEUROLOGY (2017)
miR-219 Cooperates with miR-338 in Myelination and Promotes Myelin Repair in the CNS
Haibo Wang et al.
DEVELOPMENTAL CELL (2017)
Optimizing treatment success in multiple sclerosis
Tjalf Ziemssen et al.
JOURNAL OF NEUROLOGY (2016)
Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome
Giulio Disanto et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Vitamin D and axonal injury in multiple sclerosis
L. Sandberg et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Vitamin D and axonal injury in multiple sclerosis
L. Sandberg et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Subodh Kumar et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
Jens Kuhle et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2016)
Cerebrospinal fluid chitinase-3-like 2 and chitotriosidase are potential prognostic biomarkers in early multiple sclerosis
M. Mollgaard et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis
Joachim Burman et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
M. Alba Mane-Martinez et al.
JOURNAL OF NEUROIMMUNOLOGY (2016)
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
Pierre de Flon et al.
NEUROLOGY (2016)
Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model
Jes-Niels Boeckel et al.
SCIENTIFIC REPORTS (2016)
SncRNA (microRNA & snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent
Maider Munoz-Culla et al.
SCIENTIFIC REPORTS (2016)
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo
Elena Boggio et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis
Soheil Tavakolpour
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
MicroRNAs: The Role in Autoimmune Inflammation
N. M. Baulina et al.
ACTA NATURAE (2016)
A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome
Bastian Fromm et al.
ANNUAL REVIEW OF GENETICS, VOL 49 (2015)
Cerebrospinal fluid proteomics in multiple sclerosis
Ann C. Kroksveen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Defining reliable disability outcomes in multiple sclerosis
Tomas Kalincik et al.
BRAIN (2015)
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Ester Canto et al.
BRAIN (2015)
Osteopontin in Immune-mediated Diseases
S. R. Rittling et al.
JOURNAL OF DENTAL RESEARCH (2015)
Association of copeptin and cortisol in newly diagnosed multiple sclerosis patients
Agnieszka Baranowska-Bik et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis
Diana Ferraro et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed
Agnieszka Rybak-Wolf et al.
MOLECULAR CELL (2015)
Functions of neurofilaments in synapses
A Yuan et al.
MOLECULAR PSYCHIATRY (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
miRNA in multiple sclerosis: search for novel biomarkers
Roopali Gandhi
MULTIPLE SCLEROSIS JOURNAL (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
Jens Kuhle et al.
NEUROLOGY (2015)
Cerebrospinal fluid levels of chitinase 3-like 1 and neurofilament light chain predict multiple sclerosis development and disability after optic neuritis
S. Modvig et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
miRNA in multiple sclerosis: search for novel biomarkers
Roopali Gandhi
MULTIPLE SCLEROSIS JOURNAL (2015)
Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
J. Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Clinically Isolated Syndromes: Clinical Characteristics, Differential Diagnosis, and Management
Huesnue Efendi
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY (2015)
Selected Extracellular microRNA as Potential Biomarkers of Multiple Sclerosis Activity-Preliminary Study
Magdalena Justyna Kacperska et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Epigenetics of Multiple Sclerosis: An Updated Review
Cem Ismail Kucukali et al.
NEUROMOLECULAR MEDICINE (2015)
Correlation of circular RNA abundance with proliferation - exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues
Anna Bachmayr-Heyda et al.
SCIENTIFIC REPORTS (2015)
The emerging role of circulating microRNAs as biomarkers in autoimmune diseases
Li Zeng et al.
AUTOIMMUNITY (2014)
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis
Pietro Iaffaldano et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
Osteopontin as a therapeutic target for cancer
Monalisa Bandopadhyay et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Increased Circulating Th17 Cell Populations and Elevated CSF Osteopontin and IL-17 Concentrations in Patients with Guillain-Barr, Syndrome
Rong kun Han et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Novel Aspects of Glucocorticoid Actions
E. T. Uchoa et al.
JOURNAL OF NEUROENDOCRINOLOGY (2014)
CSF levels of YKL-40 are increased in MS and replaces with immunosuppressive treatment
Clas Malmestrom et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development
Pia Kivisaekk et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
Markus Axelsson et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis
Tessel F. Runia et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis
Sandra Amor et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
The multilayered complexity of ceRNA crosstalk and competition
Yvonne Tay et al.
NATURE (2014)
Detecting and characterizing circular RNAs
William R. Jeck et al.
NATURE BIOTECHNOLOGY (2014)
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
Manuel A. Friese et al.
NATURE REVIEWS NEUROLOGY (2014)
Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression
Anthony L. Traboulsee et al.
NEUROGENETICS (2014)
Natalizumab in progressive MS Results of an open-label, phase 2A, proof-of-concept trial
Jeppe Romme Christensen et al.
NEUROLOGY (2014)
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
J. Kuhle et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Roopali Gandhi et al.
ANNALS OF NEUROLOGY (2013)
Increased leptin and A-FABP levels in relapsing and progressive forms of MS
Silvia Messina et al.
BMC NEUROLOGY (2013)
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis
Elisa Ridolfi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis
Markus Axelsson et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity
Levente Szalardy et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Pathology and disease mechanisms in different stages of multiple sclerosis
Hans Lassmann
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Circular Intronic Long Noncoding RNAs
Yang Zhang et al.
MOLECULAR CELL (2013)
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13
M. Linden et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
Jeppe Romme Christensen et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
M. Khalil et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Differential microRNA expression in blood in multiple sclerosis
Helle Bach Sondergaard et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
Enrique Alvarez et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Natural RNA circles function as efficient microRNA sponges
Thomas B. Hansen et al.
NATURE (2013)
Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion
Mario Rotondi et al.
NEUROIMMUNOMODULATION (2013)
Cortisol Awakening Response Is Linked to Disease Course and Progression in Multiple Sclerosis
Simone Kern et al.
PLOS ONE (2013)
The BDNF Val66Met Polymorphism Has Opposite Effects on Memory Circuits of Multiple Sclerosis Patients and Controls
Francesco Fera et al.
PLOS ONE (2013)
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease
Solaleh Emamgholipour et al.
PLoS One (2013)
GDNF, NGF and BDNF as therapeutic options for neurodegeneration
Shelley J. Allen et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Trash or Treasure: extracellular microRNAs and cell-to-cell communication
Nobuyoshi Kosaka et al.
Frontiers in Genetics (2013)
Updates on Clinically Isolated Syndrome and Diagnostic Criteria for Multiple Sclerosis
Jacqueline F. Marcus et al.
NEUROHOSPITALIST (2013)
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
Graziella Filippini et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Copeptin and its potential role in diagnosis and prognosis of various diseases
Lidija Dobsa et al.
BIOCHEMIA MEDICA (2013)
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
Xuguang Tai et al.
BLOOD (2012)
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
Celia Oreja-Guevara et al.
BMC NEUROLOGY (2012)
The Impact of Osteopontin Gene Variations on Multiple Sclerosis Development and Progression
Cristoforo Comi et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Regulating the immune system via IL-15 transpresentation
Eliseo F. Castillo et al.
CYTOKINE (2012)
Proteomic Analysis of Cerebrospinal Fluid in a Fulminant Case of Multiple Sclerosis
Judit Fuvesi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Serum YKL-40 following resection for cerebral glioblastoma
Daniela Bernardi et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course
Inger-Lise Mero et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients
Shi-Rong Wen et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Expansion of Neurofilament Medium C Terminus Increases Axonal Diameter Independent of Increases in Conduction Velocity or Myelin Thickness
Devin M. Barry et al.
JOURNAL OF NEUROSCIENCE (2012)
Peripherin Is a Subunit of Peripheral Nerve Neurofilaments: Implications for Differential Vulnerability of CNS and Peripheral Nervous System Axons
Aidong Yuan et al.
JOURNAL OF NEUROSCIENCE (2012)
Clinically isolated syndromes
David H. Miller et al.
LANCET NEUROLOGY (2012)
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
Timucin Avsar et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Evaluation of the relationship between leptin, resistin, adiponectin and natural regulatory T cells in relapsing-remitting multiple sclerosis
Lukasz Kraszula et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2012)
Rituximab combination therapy in relapsing multiple sclerosis
Anne H. Cross et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Impaired neurosteroid synthesis in multiple sclerosis
Farshid Noorbakhsh et al.
BRAIN (2011)
Patterns of Th1/Th2 Cytokines Predict Clinical Response in Multiple Sclerosis Patients Treated with Glatiramer Acetate
Hayrettin Tumani et al.
EUROPEAN NEUROLOGY (2011)
Axonal damage in the making: Neurofilament phosphorylation, proton mobility and magnetisation transfer in multiple sclerosis normal appearing white matter
A. Petzold et al.
EXPERIMENTAL NEUROLOGY (2011)
A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40
Sandeep K. Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma
Ralph A. Francescone et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
M. Axelsson et al.
JOURNAL OF NEUROLOGY (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course
Mohsen Khademi et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid
Samia Ragheb et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
The emerging role of microRNAs in multiple sclerosis
Andreas Junker et al.
NATURE REVIEWS NEUROLOGY (2011)
Multivesicular bodies in neurons: Distribution, protein content, and trafficking functions
Christopher S. Von Bartheld et al.
PROGRESS IN NEUROBIOLOGY (2011)
Sexually Dimorphic Effect of the Val66Met Polymorphism of BDNF on Susceptibility to Alzheimer's Disease: New Data and Meta-Analysis
Noriko Fukumoto et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2010)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
Antonio Scalfari et al.
BRAIN (2010)
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
Manuel Comabella et al.
BRAIN (2010)
At the crossroad between immunity and metabolism: focus on leptin
Javier Conde et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Regulatory Effects of Interferon-beta on Osteopontin and Interleukin-17 Expression in Multiple Sclerosis
Jian Hong et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)
In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases
Dafna Bonneh-Barkay et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
T. L. Petryshen et al.
MOLECULAR PSYCHIATRY (2010)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis - A 52-week phase II trial
R. T. Naismith et al.
NEUROLOGY (2010)
The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
Johannes Brettschneider et al.
PLOS ONE (2010)
The stress hormone copeptin: a new prognostic biomarker in acute illness
Mira Katan et al.
SWISS MEDICAL WEEKLY (2010)
Copeptin: A Novel, Independent Prognostic Marker in Patients with Ischemic Stroke
Mira Katan et al.
ANNALS OF NEUROLOGY (2009)
YKL-40 tissue expression and plasma levels in patients with ovarian cancer
Estrid V. S. Hogdall et al.
BMC CANCER (2009)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47
Andreas Junker et al.
BRAIN (2009)
Ethnic Differences in Brain-derived Neurotrophic Factor Val66Met Polymorphism in Croatian and Korean Healthy Participants
Nela Pivac et al.
CROATIAN MEDICAL JOURNAL (2009)
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers
M. Khademi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Most mammalian mRNAs are conserved targets of microRNAs
Robin C. Friedman et al.
GENOME RESEARCH (2009)
MicroRNA in autoimmunity and autoimmune diseases
Kaleb M. Pauley et al.
JOURNAL OF AUTOIMMUNITY (2009)
BDNF splice variants from the second promoter cluster support cell survival of differentiated neuroblastoma upon cytotoxic stress
Baj Gabriele et al.
JOURNAL OF CELL SCIENCE (2009)
MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis
Changsheng Du et al.
NATURE IMMUNOLOGY (2009)
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS
F. Sellebjerg et al.
NEUROLOGY (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis
Soheli A. Chowdhury et al.
ARCHIVES OF NEUROLOGY (2008)
Leptin Signaling in Breast Cancer: An Overview
Donatella Cirillo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection
David Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the polish population. Gender differences
Dagmara Mirowska-Guzel et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Lymphoid chemokines in chronic neuroinflammation
Francesca Aloisi et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Clinical markers of therapeutic response to disease modifying drugs
Carlo Pozzilli et al.
NEUROLOGICAL SCIENCES (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Copeptin: clinical use of a new biomarker
Nils G. Morgenthaler et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2008)
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor
Robert Zivadinov et al.
HUMAN MOLECULAR GENETICS (2007)
Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis
Frida Lundmark et al.
NATURE GENETICS (2007)
Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis
Simon G. Gregory et al.
NATURE GENETICS (2007)
Dissecting the human BDNF locus:: Bidirectional transcription, complex splicing, and multiple promoters
Priit Pruunsild et al.
GENOMICS (2007)
Antibodies against light neurofilaments in multiple sclerosis patients
A. Bartos et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Strain rate-dependent induction of reactive astrogliosis and cell death in three-dimensional neuronal-astrocytic co-cultures
D. Kacy Cullen et al.
BRAIN RESEARCH (2007)
Interferon-β regulates cytokines and BDNF:: greater effect in relapsing than in progressive multiple sclerosis
K. Hamomcioglu et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Processing of intronic microRNAs
Young-Kook Kim et al.
EMBO JOURNAL (2007)
Investigating the role of brain-derived neurotrophic factor in relapsing-remitting multiple sclerosis
M. Liguori et al.
GENES BRAIN AND BEHAVIOR (2007)
α-Internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS
Aidong Yuan et al.
JOURNAL OF NEUROSCIENCE (2006)
Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence
Huiping Zhang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis
Y Blanco et al.
NEUROSCIENCE LETTERS (2006)
Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis
J Brettschneider et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Natural history of multiple sclerosis: a unifying concept
C Confavreux et al.
BRAIN (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients
J Struck et al.
PEPTIDES (2005)
Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese
HT Bian et al.
NEUROSCIENCE LETTERS (2005)
The BDNF-Val66Met polymorphism: Implications for susceptibility to multiple sclerosis and severity of disease
S Lindquist et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate
D Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis
M Caggiula et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis
SM Gold et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism
D Olin et al.
NEUROSCIENCE LETTERS (2005)
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression
A Chiocchetti et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Brain-derived neurotrophic factor gene polymorphisms and Alzheimer's disease
S Matsushita et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Genetic variation in the brain derived neurotrophic factor gene in Alzheimer's disease
SM Bodner et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)
Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease
S Vepsäläinen et al.
JOURNAL OF NEUROLOGY (2005)
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes
S Baskerville et al.
RNA (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
The weight of leptin in immunity
A La Cava et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis
V Viglietta et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: The possibility to explain ethnic mental traits
E Shimizu et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Cerebrospinal fluid markers in MS patients and their healthy siblings
S Haghighi et al.
ACTA NEUROLOGICA SCANDINAVICA (2004)
Leptin and its soluble receptor in plasma of patients suffering from remitting-relapsing multiple sclerosis (MS) - In vitro effects of leptin on type-1 and type-2 cytokine secretion by peripheral blood mononuclear cells, T-cells and monocytes of MS patients
K Chatzantoni et al.
JOURNAL OF AUTOIMMUNITY (2004)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions
I Huitinga et al.
ANNALS OF NEUROLOGY (2004)
Identification of mammalian microRNA host genes and transcription units
A Rodriguez et al.
GENOME RESEARCH (2004)
Increased frequencies of serum antibodies to neurofilament light in patients with primary chronic progressive multiple sclerosis
R Ehling et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
The neurofilament middle molecular mass subunit carboxyl-terminal tail domains is essential for the radial growth and cytoskeletal architecture of axons but not for regulating neurofilament transport rate
MV Rao et al.
JOURNAL OF CELL BIOLOGY (2003)
Leptin as a marker of multiple sclerosis activity in patients treated with interferon-beta
AP Batocchi et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Brain-derived neurotrophic factor in patients with multiple sclerosis
P Sarchielli et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
A Petzold et al.
BRAIN (2002)
Dynamic processing of neuropeptides - Sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport
R Acher et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis
ZA Erkut et al.
MULTIPLE SCLEROSIS JOURNAL (2002)
BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?
C Stadelmann et al.
BRAIN (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
C Bjartmar et al.
CURRENT OPINION IN NEUROLOGY (2001)
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
LF Eng et al.
NEUROCHEMICAL RESEARCH (2000)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)